Camargo-Salamanca A, Pinto-Ramírez J, Orozco-de la Hoz C, García-López A, Patino-Jaramillo N, Girón-Luque F

Language: Spanish
References: 14
Page: 125-129
PDF size: 352.18 Kb.

ABSTRACT

COVID-19 disease is a systemic infection associated with renal damage leading to acute kidney injury with acute tubular necrosis and several types of podocytopathies. We report a clinical case in a kidney transplant patient diagnosed with COVID-19 disease, acute kidney injury and nephrotic syndrome. SARS-CoV 2 PCR results in nasal swab was positive and kidney was negative. Renal histopathologic findings described minimal change disease. So far, this case is the first clinical report of minimal change disease associated to COVID-19 in a kidney transplant patient.

REFERENCES

1. Ronco C, Reis T, Husain-Syed F. Management ofacute kidney injury in patients with COVID-19.Lancet Respir Med. 2020;8(7):738-42. doi: 10.1016/S2213-2600(20)30229-0.

2. Hong D, Long L, Wang AY, Lei Y, Tang Y, Zhao JW,et al. Kidney manifestations of mild, moderate andsevere coronavirus disease 2019: a retrospective cohortstudy. Clin Kidney J. 2020;13(3):340-6. doi: 10.1093/ckj/sfaa083.

3. Lubetzky M, Aull MJ, Craig-Schapiro R, Lee JR,Marku-Podvorica J, Salinas T, et al. Kidney allograftrecipients, immunosuppression, and coronavirusdisease-2019: a report of consecutive cases from a NewYork City transplant center. Nephrol Dial Transplant.2020;35(7):1250-61. doi: 10.1093/ndt/gfaa154.

4. Batlle D, Soler MJ, Sparks MA, Hiremath S, SouthAM, Welling PA, et al.; COVID-19 and ACE2 inCardiovascular, Lung, and Kidney Working Group.Acute kidney injury in COVID-19: emerging evidenceof a distinct pathophysiology. J Am Soc Nephrol.2020;31(7):1380-3. doi: 10.1681/ASN.2020040419.

5. Kudose S, Batal I, Santoriello D, Xu K, Barasch J,Peleg Y, et al. Kidney biopsy findings in patients withCOVID-19. J Am Soc Nephrol. 2020;31(9):1959-68.doi: 10.1681/ASN.2020060802.

6. Larsen CP, Bourne TD, Wilson JD, Saqqa O,Sharshir MA. Collapsing glomerulopathy in a patientwith coronavirus disease 2019 (COVID-2019).Kidney Int Rep. 2020;5(6):935-9. doi: 10.1016/j.ekir.2020.04.002.

7. Lazareth H, Péré H, Binois Y, Chabannes M, SchurderJ, Bruneau T, et al. COVID-19-related collapsingglomerulopathy in a kidney transplant recipient.Am J Kidney Dis. 2020;76(4):590-4. doi: 10.1053/j.ajkd.2020.06.009.

8. Ahn W, Bomback AS. Approach to diagnosis andmanagement of primary glomerular diseases due topodocytopathies in adults: core curriculum 2020.Am J Kidney Dis. 2020;75(6):955-64. doi: 10.1053/j.ajkd.2019.12.019.

9. Wada T, Nangaku M. A circulating permeabilityfactor in focal segmental glomerulosclerosis: the huntcontinues. Clin Kidney J. 2015;8(6):708-15. doi:10.1093/ckj/sfv090.

10. Lai Q, Spoletini G, Bianco G, Graceffa D, Agnes S,Rossi M, et al. SARS-CoV2 and immunosuppression:A double-edged sword. Transpl Infect Dis.2020;22(6):e13404. doi: 10.1111/tid.13404.

11. Massoth LR, Desai N, Szabolcs A, Harris CK,Neyaz A, Crotty R, et al. Comparison of RNA in situhybridization and immunohistochemistry techniquesfor the detection and localization of SARS-CoV-2 inhuman tissues. Am J Surg Pathol. 2021;45(1):14-24.doi: 10.1097/PAS.0000000000001563.

12. Lazareth H, Péré H, Binois Y, Chabannes M,Schurder J, Bruneau T, et al. COVID-19-relatedcollapsing glomerulopathy in a kidney transplantrecipient. Am J Kidney Dis. 2020;76(4):590-4. doi:10.1053/j.ajkd.2020.06.009.

13. Sun DQ, Wang TY, Zheng KI, Targher G, ByrneCD, Chen YP, et al. Subclinical acute kidneyinjury in COVID-19 patients: a retrospectivecohort study. Nephron. 2020;144(7):347-50. doi:10.1159/000508502.

14. Husain-Syed F, Wilhelm J, Kassoumeh S, BirkHW, Herold S, Vadász I, et al. Acute kidney injuryand urinary biomarkers in hospitalized patients withcoronavirus disease-2019. Nephrol Dial Transplant.2020;35(7):1271-4. doi: 10.1093/ndt/gfaa162.